Modulation of phenotype of human prostatic stromal cells by transforming growth factor‐betas
- 5 November 2003
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 58 (2) , 174-182
- https://doi.org/10.1002/pros.10320
Abstract
BACKGROUND: We investigated the effects of transforming growth factor (TGF)‐betas on morphological and receptor phenotypes, as well as proliferation of four currently established human prostatic myofibroblast cell lines and one commercially available prostatic stromal cell line.METHODS: The effects of TGF‐betas on morphological changes and proliferation of the cells were studied by immunohistochemistry and bromodeoxyuridine assay, respectively. The expression of alpha 1‐receptor subtypes was measured by real time quantitative reverse transcription‐polymerase chain reaction (RT‐PCR) and the radioligand binding assay for the receptors was also performed.RESULTS: TGF‐betas 1, 2, and 3 induced expression of desmin and myosin of cells of the established cell lines, and significantly inhibited their growth. The alpha 1a‐receptor was expressed only in the commercially available cell line and alpha 1b and 1d, in all cell lines. TGF‐beta 1 suppressed the expression of all three subtypes of the alpha 1‐receptor. The binding sites of cells of all the cell lines were reduced by treatment with this growth factor.CONCLUSIONS: TGF‐betas may induce human prostatic stromal cells to express the smooth muscle phenotype and inhibited their growth. However, the growth factor reduced the binding sites of the receptor and suppressed mRNA expression of its subtypes, suggesting that morphological and receptor phenotypes may be regulated via more than one pathway by TGF‐beta(s).Keywords
This publication has 25 references indexed in Scilit:
- Mechanical Tension Controls Granulation Tissue Contractile Activity and Myofibroblast DifferentiationThe American Journal of Pathology, 2001
- Apoptotic activity of doxazosin on prostate stroma in vitro is mediated through an autocrine expression of TGF‐β1The Prostate, 2001
- alpha 1-ADRENOCEPTOR ANTAGONISTS TERAZOSIN AND DOXAZOSIN INDUCE PROSTATE APOPTOSIS WITHOUT AFFECTING CELL PROLIFERATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 1999
- Modulation of the differentiation status of cultured prostatic smooth muscle cells by an ?1-adrenergic receptor antagonistThe Prostate, 1999
- Induction of Smooth Muscle Cell Phenotype in Cultured Human Prostatic Stromal CellsExperimental Cell Research, 1997
- Human prostatic smooth muscle cells in culture: Estradiol enhances expression of smooth muscle cell-specific markersThe Prostate, 1997
- NS-49, a novel α1a-adrenoceptor-selective agonist characterization using recombinant human α1-adrenoceptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Transforming Growth Factor β-1 Modulates the Number of β-Adrenergic Receptors in Cardiac FibroblastsJournal of Molecular and Cellular Cardiology, 1994
- The alpha‐adrenoceptor subtype mediating the tension of human prostatic smooth muscleThe Prostate, 1993
- Influence of transforming growth factor β1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate‐derived fibroblastsThe Prostate, 1993